- Home
- WBX vs ANIX Comparison
WBX vs ANIX Comparison
Compare WBX & ANIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WBX | ANIX |
|---|---|---|
| Founded | 2015 | 1982 |
| Country | Spain | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 118.0M | 104.0M |
| IPO Year | N/A | 1987 |
Fundamental Metrics
Financial Performance| Metric | WBX | ANIX |
|---|---|---|
| Price | $2.63 | $2.83 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 3 |
| Target Price | $9.00 | $9.00 |
| AVG Volume (30 Days) | 11.1K | ★ 223.9K |
| Earning Date | 03-04-2026 | 03-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $174,593,453.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $37.11 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.30 | $2.33 |
| 52 Week High | $12.30 | $5.46 |
Technical Indicators
Market Signals| Indicator | WBX | ANIX |
|---|---|---|
| Relative Strength Index (RSI) | 39.85 | 38.67 |
| Support Level | $2.51 | $2.69 |
| Resistance Level | $2.99 | $3.04 |
| Average True Range (ATR) | 0.14 | 0.19 |
| MACD | -0.02 | 0.01 |
| Stochastic Oscillator | 20.69 | 21.97 |
Price Performance
Historical ComparisonAbout WBX Wallbox N.V.
Wallbox NV is a smart electric vehicle charging and energy management company. It creates a smart charging system combining technology design that manages the communication between the user, vehicle, grid, building, and charger. The company designs, manufactures, and distributes faster, simpler EV charging solutions for residential, business, and public use. Its smart charging product portfolio includes Level 2 alternating current chargers for home and business applications and direct current fast chargers for public applications. The company has three reportable operating segments; Europe, Middle East and Asia (EMEA), its key revenue-generating segment, North America, and Asia-Pacific.
About ANIX Anixa Biosciences Inc.
Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.